Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_assertion type Assertion NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_head.
- NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_assertion description "[Along with SM22? induction in PHN, confirmed at both mRNA and protein levels, SM22? was also induced across a broad range of proteinuric diseases, including experimental animal models (puromycin aminonucleoside nephropathy, adriamycin nephropathy, passive nephrotoxic nephritis, and diet-induced obesity) and human diseases (collapsing glomerulopathy, diabetic nephropathy, classic focal segmental glomerulosclerosis, IgA nephropathy, minimal-change disease, membranous nephropathy, and membranoproliferative glomerulonephritis).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_provenance.
- NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_assertion evidence source_evidence_literature NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_provenance.
- NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_assertion SIO_000772 21289056 NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_provenance.
- NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_assertion wasDerivedFrom befree-20150227 NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_provenance.
- NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_assertion wasGeneratedBy ECO_0000203 NP722237.RASxIv-S8D0HpuNEf9-tt1mH-VjXwi_WRTW54MfdCoCxU130_provenance.